We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Industrials 3.56%
3 Consumer Discretionary 3.22%
4 Technology 3.15%
5 Healthcare 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
2401
Atlassian
TEAM
$41.2B
$4K ﹤0.01%
32
-3,013
-99% -$421K
TEX icon
2402
Terex
TEX
$7.76B
$4K ﹤0.01%
+308
New +$6.97K
TSQ icon
2403
Townsquare Media
TSQ
$104M
$4K ﹤0.01%
+914
New +$7.57K
ULH icon
2404
Universal Logistics Holdings
ULH
$509M
$4K ﹤0.01%
301
-586
-66% -$9.66K
VANI icon
2405
Vivani Medical
VANI
$121M
$4K ﹤0.01%
+1,185
New +$15.6K
VMI icon
2406
Valmont Industries
VMI
$9.56B
$4K ﹤0.01%
42
-178
-81% -$23.1K
WOW
2407
DELISTED
WideOpenWest
WOW
$4K ﹤0.01%
+934
New +$5.67K
XERS icon
2408
Xeris Biopharma Holdings
XERS
$1.57B
$4K ﹤0.01%
2,140
-5,653
-73% -$24.3K
XXII
2409
22nd Century Group
XXII
$1.49M
0
BERY
2410
DELISTED
Berry Global Group, Inc.
BERY
$4K ﹤0.01%
138
-571
-81% -$20.9K
SCTL
2411
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$4K ﹤0.01%
475
-1,063
-69% -$14.8K
NEPT
2412
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$4K ﹤0.01%
2
-3
-60% -$8.54K
LVOX
2413
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$4K ﹤0.01%
+400
New +$4K
PCTI
2414
DELISTED
PCTEL, Inc. Common Stock
PCTI
$4K ﹤0.01%
632
-805
-56% -$6.13K
CTG
2415
DELISTED
Computer Task Group, Inc.
CTG
$4K ﹤0.01%
1,077
-2,601
-71% -$13.7K
MMP
2416
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4K ﹤0.01%
118
+117
+11,700% +$6.28K
ROCC
2417
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$4K ﹤0.01%
+1,347
New +$22.4K
ELOX
2418
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$4K ﹤0.01%
53
+13
+33% +$2.12K
CLR
2419
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$4K ﹤0.01%
516
-4,089
-89% -$91.2K
MTOR
2420
DELISTED
MERITOR, Inc.
MTOR
$4K ﹤0.01%
271
-6,426
-96% -$138K
GWGH
2421
DELISTED
GWG Holdings, Inc
GWGH
$4K ﹤0.01%
+372
New +$3.52K
XLNX
2422
DELISTED
Xilinx Inc
XLNX
$4K ﹤0.01%
56
-2,418
-98% -$211K
CCRC
2423
DELISTED
China Customer Relations Centers, Inc
CCRC
$4K ﹤0.01%
+884
New +$7.16K
LINX
2424
DELISTED
Linx S.A.
LINX
$4K ﹤0.01%
+1,360
New +$9.49K
CCX.U
2425
DELISTED
Churchill Capital Corp II
CCX.U
$4K ﹤0.01%
414
+14
+4% +$157

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.6% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.